Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Study Between Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients

NCT06750458 is registered in ClinicalTrials.gov with Tanta University as lead sponsor.

NCT NCT06750458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06750458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Study Between Dapagliflozin Versus Dexamethasone Role in Pre-operative Management of Non- Diabetic Brain Tumor Patients
Lead sponsor
Tanta University
Phase
Phase 3
Overall status
Completed
Start date
January 20, 2025
Completion date
September 20, 2026
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dapagliflozin (forxiga), dexamethasone, glioma